Literature DB >> 3354808

Intrathecal buprenorphine for postoperative analgesia in the elderly patient.

G Capogna1, D Celleno, V Tagariello, C Loffreda-Mancinelli.   

Abstract

Ninety patients aged 56-85 years scheduled for suprapubic prostatectomy, randomly received intrathecally either bupivacaine 30 mg (group A, n = 30), bupivacaine 30 mg plus buprenorphine 0.03 mg (group B, n = 30) or bupivacaine 30 mg plus buprenorphine 0.045 mg (group C, n = 30). Prolonged postoperative analgesia, minimal disturbance of consciousness and comfortable breathing were common to the groups that received buprenorphine. The higher concentration of buprenorphine improved the quality and duration of analgesia. The only side effects found in the buprenorphine groups were nausea and vomiting in 11 and 14 patients, respectively, in groups B and C. Our study shows that buprenorphine is an effective analgesic, suitable for the management of postoperative pain in elderly patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3354808     DOI: 10.1111/j.1365-2044.1988.tb05482.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  11 in total

Review 1.  Opioid agonist-antagonist drugs in acute and chronic pain states.

Authors:  P J Hoskin; G W Hanks
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

2.  Comparison of intrathecal dexmedetomidine with buprenorphine as adjuvant to bupivacaine in spinal asnaesthesia.

Authors:  Mahima Gupta; S Shailaja; K Sudhir Hegde
Journal:  J Clin Diagn Res       Date:  2014-02-03

3.  Role of buprenorphine in prolonging the duration of post-operative analgesia in percutaneous nephrolithotomy: Comparison between bupivacaine versus bupivacaine and buprenorphine combination.

Authors:  Jonnavithula Nirmala; Anil Kumar; Rahul Devraj; Sriramoju Vidyasagar; Gunta Ramachandraiah; Pisapati V L N Murthy
Journal:  Indian J Urol       Date:  2015 Apr-Jun

4.  Intrathecal buprenorphine versus fentanyl as adjuvant to 0.75% ropivacaine in lower limb surgeries.

Authors:  Arvinder Pal Singh; Ravinder Kaur; Ruchi Gupta; Anita Kumari
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2016 Apr-Jun

5.  Intrathecal Hyperbaric Bupivacaine with Varying Doses of Buprenorphine for Postoperative Analgesia after Cesarean Section: A Comparative Study.

Authors:  Rashmi Ravindran; Binu Sajid; Konnanath Thekkethil Ramadas; Indu Susheela
Journal:  Anesth Essays Res       Date:  2017 Oct-Dec

6.  Comparative Effects of Buprenorphine and Dexmedetomidine as Adjuvants to Bupivacaine Spinal Anaesthesia in Elderly Male Patients Undergoing Transurethral Resection of Prostrate: A Randomized Prospective Study.

Authors:  Navdeep Kaur; Umesh Goneppanavar; Ramkumar Venkateswaran; Sadasivan Shankar Iyer
Journal:  Anesth Essays Res       Date:  2017 Oct-Dec

7.  A prospective randomized study on the impact of low-dose dexamethasone on perioperative blood glucose concentrations in diabetics and nondiabetics.

Authors:  Athul M Purushothaman; Vinayak Seenappa Pujari; Nalini B Kadirehally; Yatish Bevinaguddaiah; Pratheek R Reddy
Journal:  Saudi J Anaesth       Date:  2018 Apr-Jun

8.  Comparison of Intrathecal Fentanyl and Buprenorphine as an Adjuvant to 0.5% Hyperbaric Bupivacaine for Spinal Anesthesia.

Authors:  Tanvi A Dhawale; K R Sivashankar
Journal:  Anesth Essays Res       Date:  2021-08-30

9.  Comparative Evaluation of Intrathecal Bupivacaine 0.5% With Intrathecal Bupivacaine 0.5% and 60-µg Buprenorphine for Postoperative Analgesia in Elective Cesarean Section Patients.

Authors:  T R Shrinivas; Liyakhath Ali; Siddharam Jamagond
Journal:  J Pharm Bioallied Sci       Date:  2022-07-13

10.  Comparison of hemodynamic response and postoperative pain score between general anaesthesia with intravenous analgesia versus general anesthesia with caudal analgesia in pediatric patients undergoing open-heart surgery.

Authors:  Dharma Jivan Samantaray; Meena Trehan; Vivek Chowdhry; Satish Reedy
Journal:  Ann Card Anaesth       Date:  2019 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.